Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes

scientific article published on 9 September 2014

Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2337/DB14-0621
P698PubMed publication ID25204978
P5875ResearchGate publication ID265518066

P50authorPatrizia AgostinisQ30111808
Abhishek D. GargQ38322540
An StaesQ49049688
Chantal MathieuQ54656098
Lut OverberghQ92483088
Gabriela Bomfim FerreiraQ113940295
P2093author name stringKris Gevaert
Decio L Eizirik
Dieter Rondas
Inne Crèvecoeur
Wannes D'Hertog
P433issue2
P407language of work or nameEnglishQ1860
P921main subjecttype-1 diabetesQ124407
P304page(s)573-586
P577publication date2014-09-09
P1433published inDiabetesQ895262
P1476titleCitrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes
P478volume64

Reverse relations

cites work (P2860)
Q53604777A proteomic study of the regulatory role for STAT-1 in cytokine-induced beta-cell death.
Q90350796Accurate Identification of Deamidation and Citrullination from Global Shotgun Proteomics Data Using a Dual-Search Delta Score Strategy
Q51350685An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse.
Q95660427An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells
Q37478584Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
Q91262574Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies
Q40998700Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children
Q40561404Antibodies to post-translationally modified insulin in type 1 diabetes
Q26751244Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets
Q60045810Bioluminescent reporter assay for monitoring ER stress in human beta cells
Q47614555Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.
Q92635532Cell surface expression of 78-kDa glucose-regulated protein (GRP78) mediates diabetic nephropathy
Q38358009Combination immunotherapies for type 1 diabetes mellitus
Q52344613Current Strategies to Enhance Anti-Tumour Immunity.
Q64070945Cytokine-induced translocation of GRP78 to the plasma membrane triggers a pro-apoptotic feedback loop in pancreatic beta cells
Q36515404Detection and identification of protein citrullination in complex biological systems
Q57201489Determining T-cell specificity to understand and treat disease
Q39025801Early differences in islets from prediabetic NOD mice: combined microarray and proteomic analysis
Q26749276Endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation
Q38975660Endoplasmic reticulum stress in beta cells and autoimmune diabetes
Q42369799Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes
Q92138571Exploiting CD22 To Selectively Tolerize Autoantibody Producing B-Cells in Rheumatoid Arthritis
Q57063918Human Mesenchymal Stem Cell Secretome from Bone Marrow or Adipose-Derived Tissue Sources for Treatment of Hypoxia-Induced Pulmonary Epithelial Injury
Q55283549IRE1α Implications in Endoplasmic Reticulum Stress-Mediated Development and Pathogenesis of Autoimmune Diseases.
Q88763199Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance
Q30391892Immune recognition of citrullinated epitopes
Q57786914Inflammation-Induced Citrullinated Glucose-Regulated Protein 78 Elicits Immune Responses in Human Type 1 Diabetes
Q38771484Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes
Q58715113Islet stress, degradation and autoimmunity
Q52719485Modifying Enzymes are Elicited by ER Stress, Generating Epitopes that are Selectively Recognized by CD4+ T Cells in Patients With Type 1 Diabetes.
Q36301061Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
Q45028780NETosis-associated serum biomarkers are reduced in type 1 diabetes in association with neutrophil count
Q37698306Narrowing in on the anti-β cell-specific T cells: looking 'where the action is'.
Q58606564Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes
Q38539481New Insights and Biomarkers for Type 1 Diabetes: Review for Scandinavian Journal of Immunology.
Q89583558Novel tumour antigens and the development of optimal vaccine design
Q45989245Oxidative Modifications in Tissue Pathology and Autoimmune Disease.
Q89805633Peptidyl Arginine Deiminase 2 (PADI2)-Mediated Arginine Citrullination Modulates Transcription in Cancer
Q97518206Prediction and Prevention of Type 1 Diabetes
Q34468829Prelude to oral microbes and chronic diseases: past, present and future
Q36098256Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury
Q46303593Reactive oxygen species inhibit catalytic activity of peptidylarginine deiminase
Q26766139Recent advances in understanding Type 1 Diabetes
Q41092744Reduced glutathione as a physiological co-activator in the activation of peptidylarginine deiminase
Q64883448Release of active peptidylarginine deiminase into the circulation during acute inflammation induced by coronary artery bypass surgery.
Q91137776Serum biomarkers for diagnosis and prediction of type 1 diabetes
Q26787014T cell epitopes and post-translationally modified epitopes in type 1 diabetes
Q88301749The Rheumatoid Arthritis-Associated Citrullinome
Q38340362The beta-cell in type 1 diabetes: What have we learned from proteomic studies?
Q48003839The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse
Q48720838The progress and potential of proteomic biomarkers for type 1 diabetes in children
Q64234727Thioredoxin Modulates Protein Arginine Deiminase 4 (PAD4)-Catalyzed Citrullination
Q90080201Type I interferons and endoplasmic reticulum stress in health and disease
Q39398068Understanding type 1 diabetes through proteomics
Q26750714Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis
Q38637035β cell ER stress and the implications for immunogenicity in type 1 diabetes

Search more.